Emerson Electric 10-Kyear ended 2026-09-30

Executive Summary

Emerson sells automation equipment, control systems, industrial software and testing technology to process manufacturers, hybrid and discrete industries, earning revenue from products, software and services. Its transformation toward industrial technology now centers on integrating AspenTech and National Instruments while developing software-defined automation and industrial AI. FY2026 sales rose 5.4% to $19.0B, with stronger software-and-systems demand and a return to profitability in Test & Measurement supporting that direction. However, pricing contributed more than volume to underlying growth, and tariff refunds and lower acquisition costs helped earnings. The investment case rests on converting a growing backlog into sustained product demand and profits, while managing acquisition-related financing and weaker international markets.

What's Happening in the Business

Emerson reorganized into five reporting segments in FY2026, bringing its acquired software and testing businesses into a clearer automation-focused structure. AspenTech, wholly owned since 3/2025, sits within Control Systems & Software; National Instruments forms Test & Measurement. Management intends the portfolio to deliver higher growth and margins, supported by software-defined automation, self-optimizing asset software and sustainability solutions.

Software & Systems supplied the strongest growth. Demand from power, life sciences, aerospace and defense, and semiconductor customers helped offset software-renewal timing that reduced the group’s volume growth by two percentage points. Elsewhere, demand was less convincing: Intelligent Devices had flat underlying volume, while Safety & Productivity volume declined.

The order book supports further growth. Backlog reached $9.59B, up 11%, with ≈70% expected to become revenue within the following year. Software & Systems accounted for most of the increase. Engineering, development and customer-funded engineering spending rose to 8.3% of sales from 8.1%, supporting Emerson’s technology push.

Key Financial Highlights

• Growth quality: Underlying sales increased 4%, from 3% in FY2025, comprising 3% pricing and 1% volume. U.S. underlying growth was 9% vs 1% internationally; China sales in Intelligent Devices fell 11%.
• Segment profitability: Software & Systems margin reached 17.2%, from 14.4%, as Test & Measurement recovered. Safety & Productivity’s 2% volume decline and higher restructuring costs offset pricing benefits.
• Unusual earnings support: Tariff refunds reduced cost of sales by $121M; Emerson contributed $30.0M to a charitable trust. Acquisition/divestiture costs fell $174M and backlog amortization fell $65.0M. These benefits are not equivalent to recurring demand growth.
• Costs outside segments: Corporate and other deductions fell to $211M from $455M, chiefly reflecting fewer acquisition-related costs. Net interest expense increased 41% to $334M, partly offsetting those savings.
• Cash generation: Continuing-operations FCF reached $3.54B, up 8.9%. Working capital absorbed $338M vs $9.00M previously, including increased inventory. The larger improvement in total operating cash flow also reflects prior-year Copeland-sale tax payments.
• Capital allocation: Repurchases were $1.00B vs $1.17B; dividends were $1.24B vs $1.19B. After treasury-share issuance, shares outstanding fell 1.0% to 557M.
• Acquisition exposure: Goodwill of $18.1B and other intangible assets of $8.44B exceeded total equity, leaving tangible equity of $(5.79)B. This makes acquired-business performance important beyond its immediate contribution to earnings.

Risk Assessment

• Acquisition execution and valuation: AspenTech and National Instruments must deliver expected growth and profitability; disappointing cash flows could trigger impairments against Emerson’s acquisition-heavy asset base.
• Demand and geopolitical exposure: Weak Chinese demand and Middle East disruption constrain volume, while management’s outlook assumes the conflict stays contained within the region.
• Refinancing and liquidity: Short-term borrowings and current debt maturities of $4.67B exceed cash of $1.81B, making continued funding access important despite undrawn credit facilities.
• Trade and supply chains: Extensive overseas manufacturing and reliance on electronics, metals and other inputs expose Emerson to changing tariffs, export restrictions and shipment disruptions.
• Connected-product security: Cyberattacks or defects in control systems, software and instrumentation could interrupt customer operations and create safety, liability and reputational costs.

What to Watch

• Software adoption and renewals: Control Systems & Software growth currently includes renewal-timing pressure. Later filings should show whether renewals recover and software-defined automation wins customers, or whether delayed revenue persists.
• Test & Measurement recovery: Revenue grew 17% and earnings turned positive. Sustained growth with improving profitability would validate the National Instruments investment; renewed losses would weaken that case.
• Backlog conversion and geographic demand: The growing backlog offers visibility, but international growth is weak. Successful conversion alongside broader volume growth would support the outlook; delays or cancellations would undermine it.
• FY2027 cash and capital returns: Management forecasts ≈5% sales growth, ≈$5.70 GAAP EPS and ≈$7.25 adjusted EPS. Planned shareholder returns of ≈$3.8B nearly consume forecast FCF of $3.8–$3.9B; delivery would support distributions, while a shortfall would constrain debt reduction.